Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.6% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07090395Not ApplicableRecruiting

Severe Label Expansion for EVO Products Trial

Role: lead

NCT07397780Active Not Recruiting

RPMO2 Oximeter Accuracy During Sleep 1 Trial

Role: lead

NCT06267976Completed

Validation of the ProSomnus® RPMO2 Device

Role: lead

NCT05445869Not ApplicableTerminated

Severe OSA Study (SOS)

Role: lead

All 4 trials loaded